StonvexLoading…
StonvexCore line items from MAN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $4.51B | $17.96B | $13.24B | $8.61B |
Operating Income | $28.30M | $150.10M | $69.50M | $2.90M |
Net Income | $2.50M | $-13.30M | $-43.50M | $-67.10M |
EPS (Diluted) | $0.05 | $-0.29 | $-0.93 | $-1.32 |
Total Assets | $8.39B | $9.16B | $8.45B | $8.51B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $224.90M | $871.00M | $274.60M | $289.80M |
Free Cash Flow OCF − CapEx | $-135.30M | $-161.40M | $-329.40M | $-374.10M |
Shares Outstanding | 47.10M | 46.60M | 46.60M | 46.70M |